Test Price
2,800 AEDโ Home Collection Available
GNPTG Gene Mucolipidosis Type III Gamma Genetic Test in UAE | 2800 AED | Molecular Diagnosis
Executive Summary & Core Metrics
- Diagnostic Accuracy 99.9%: ISO-accredited next-generation sequencing achieving full GNPTG gene coverage with high clinical sensitivity.
- Premium Home Collection Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain sample transport available daily from 8 AM to 11 PM.
- Post-Test Clinical Guidance: Telephonic result interpretation and genetic counselling session included with every test.
- Direct Insurance Verification: WhatsApp-based billing confirmation at +971 54 548 8731.
Test Overview & Methodology
This molecular genetic test employs next-generation sequencing to detect pathogenic variants in the GNPTG gene responsible for mucolipidosis type III gamma, also known as pseudo-Hurler polydystrophy. Definitive molecular diagnosis enables early therapeutic intervention, carrier screening, and informed family planning. The analysis covers all coding exons and flanking intronic regions of the GNPTG gene.
| Parameter | Our Test (NGS) | Closest Alternative (Biochemical Enzyme Assay) |
|---|---|---|
| Precision | 99.9% sensitivity; full gene coverage | ~85% sensitivity; functional only |
| Method | Next-Generation Sequencing (NGS) | Lysosomal enzyme activity assay |
| Turnaround Time | 3โ4 Weeks | 2โ4 Weeks |
| Clinical Utility | Definitive molecular diagnosis, carrier & prenatal testing | Screening; often requires genetic confirmation |
Physician Insight & Safety Protocols
โA pathogenic GNPTG variant must always be correlated with the clinical phenotype and biochemical markers such as elevated lysosomal enzymes. Pre- and post-test genetic counselling is strongly recommended to accurately interpret results and provide comprehensive family guidance.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication & Clinical Management
Do not discontinue or alter any prescribed therapy without consulting your treating physician. This genetic test is intended to support diagnosis and management planning and does not replace ongoing metabolic or symptomatic care.
Patient Exclusion Criteria & Safety Red Flags
- Minors: Testing requires parental or guardian consent, a formal genetic counselling session, and strict adherence to Federal Decree-Law No. 4 of 2016 on Medical Liability regarding consent for minors.
- Asymptomatic Adults: Whole-gene testing without clinical indication or prior counselling is not advised; incidental findings may cause unwarranted psychological distress.
- Acute Metabolic Decompensation: Patients presenting with vomiting, lethargy, or seizures should seek emergency care immediatelyโelective genetic testing is contraindicated until stabilisation.
Emergency Red Flags: Rapid neurological deterioration, severe dehydration, or loss of consciousness. Proceed to the nearest emergency department; testing can be scheduled once the patient is stable.
Patient FAQ & Clinical Guidance
1. What is the GNPTG gene mucolipidosis type III gamma NGS test used for?
This test detects pathogenic variants in the GNPTG gene causing mucolipidosis type III gamma, enabling early molecular diagnosis and targeted management. It is indicated for patients with skeletal dysplasia, joint stiffness, and suspected lysosomal storage disorders, and supports carrier screening and family planning. Results guide specialist referrals and personalised care strategies.
2. How is the test performed and what sample is required?
A simple peripheral blood sample or extracted DNA is sequenced using next-generation sequencing technology. Alternatively, a dried blood spot on a DNA FTA card can be submitted. VIP mobile phlebotomy and temperature-controlled cold-chain home collection are available daily from 8 AM to 11 PM, with ISO-certified transport to our laboratory.
3. Is genetic counselling required before this test?
Pre-test genetic counselling is mandatory to fully understand the implications for the patient and family members before sampling. Our service includes a dedicated session to draw a detailed family pedigree, explain possible outcomes, and address ethical and psychological considerations in full compliance with UAE regulatory frameworks.
4. What is the turnaround time and how will I receive results?
The turnaround time is 3 to 4 weeks from sample receipt. Results are delivered via a secure digital portal along with a detailed molecular report and a telephonic consultation with our genetics team to explain findings and next steps.
UAE Regulatory & Data Privacy Adherence
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): Full compliance for all genomic and personal data handling, storage, and processing.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: Adherence to digital health data security and interoperability standards.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Patient consent, safety protocols, and clinical accountability frameworks strictly followed.
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) โ International quality management system for laboratory operations.
Clinical & Logistical Metadata
| Test Name | GNPTG Gene Mucolipidosis Type III Gamma Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA), extracted DNA, or dried blood spot on DNA FTA card |
| Methodology Used | Next-Generation Sequencing (NGS) โ Full gene coverage including coding exons and flanking intronic regions |
| ICD-10-CM Code | E77.0 |
| LOINC Code | 87436-6 |
| DHA Facility License & Laboratory Address | DHA Facility License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians